Pharmaceutical giant Amgen discloses a significant data breach after threat actors steal sensitive information from cloud environments operated by third-party service providers. The California-based biotechnology company, which develops medicines for cancer, cardiovascular disease, and rare illnesses, detects the unauthorized activity in July 2026 and activates its cybersecurity response plan. Amgen